Profusa, Inc. Common Stock (PFSA : NASDAQ)
Common Stock
$3.03
USD
+0.98 (47.80%)
Last updated: 2026-09-24
Follow PFSA
PFSA
Profusa, Inc. Common Stock
WealthAwesomePerformance
1 Day
+47.80%
1 Week
+68.33%
1 Month
-39.40%
YTD
-52.28%
Key Statistics
Market Cap
$1.24M
52W High
$750.00
52W Low
$0.86
P/E Ratio
-
50 Day MA
$4.77
200 Day MA
$210.36
Beta
0.47
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $3.51 | $4.18 | $2.39 | $3.03 | $3.03 | 78,690,586 |
| 9/23/2026 | $1.88 | $2.38 | $1.86 | $2.05 | $2.05 | 1,777,107 |
| 9/22/2026 | $1.89 | $2.23 | $1.85 | $2.17 | $2.17 | 3,545,753 |
| 9/21/2026 | $1.87 | $2.00 | $1.82 | $1.94 | $1.94 | 54,346 |
| 9/18/2026 | $1.82 | $2.10 | $1.81 | $1.91 | $1.91 | 197,700 |
| 9/17/2026 | $1.72 | $1.82 | $1.58 | $1.80 | $1.80 | 138,304 |
| 9/16/2026 | $1.86 | $2.28 | $1.70 | $1.78 | $1.78 | 785,311 |
| 9/15/2026 | $2.35 | $2.40 | $1.77 | $1.83 | $1.83 | 1,130,463 |
| 9/14/2026 | $2.45 | $2.67 | $2.38 | $2.59 | $2.59 | 109,614 |
| 9/11/2026 | $2.43 | $2.66 | $2.35 | $2.43 | $2.43 | 78,100 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PFSA's historical volatility
30-Day Vol
644.9%
Annualized
90-Day Vol
860.4%
Annualized
Trend (90d)
+14.8%
Annualized drift
90d Mean
US$3.19
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$3.08 | US$0.33 – US$28.54 |
| 60 trading days | US$3.14 | US$0.13 – US$73.00 |
| 90 trading days | US$3.19 | US$0.07 – US$150.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Profusa, Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -869.07
- Book Value
- -205.03
Classification
- Sector
- Health Care
- Industry
- Health Care Technology
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About PFSA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| YDES | YD Bio Ltd | $4.77 | +47.68% |